epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Polivy (polatuzumab vedotin-piiq)
    polatuzumab vedotin
  • remove Voydeya
    danicopan

multicheck MultiCheck Results - 1 Interaction

Smiley face Smiley face

Caution Advised

Smiley face Smiley face Polivy (polatuzumab vedotin-piiq) (polatuzumab vedotin) + Voydeya (danicopan)

Caution Advised


polatuzumab vedotin + danicopan

caution advised: combo may incr. risk of serious infection (additive effects)

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information